Abbott Laboratories (ABT)

Abbott Introduces Canada's First Remote Neuromodulation Patient-Care Technology, NeuroSphere™ Virtual Clinic, to Treat People with Chronic Pain and Movement Disorders*

Abbott (NYSE: ABT) announces the Health Canada licencing† of NeuroSphere™ Virtual Clinic, a remote programming technology that is the first of its kind in Canada and is compatible with Abbott's suite of neuromodulation technologies. NeuroSphere Virtual Clinic has the potential to increase access to optimal treatment for patients living with chronic pain, Parkinson's disease, or essential tremors who might otherwise have difficulty receiving care from their healthcare provider due to location or